close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Onconova Therapeutics, Inc. - Common Stock (NQ:ONTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Onconova Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Onconova Therapeutics Presents Preclinical Data Characterizing Rigosertib’s Mechanisms of Action at the AACR Targeting RAS Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
From Onconova Therapeutics, Inc.
Via GlobeNewswire
News headline image
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, November 14, 2022 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Global Brain Tumor Diagnosis & Treatment Market Could Exceed $880 Million By 2027
Via FinancialNewsMedia
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Via FinancialNewsMedia
Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants
Via FinancialNewsMedia
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today